接受抗病毒治疗的流感患者中心血管疾病患者的流感负担

数据集获取（Figshare）

• 源站标题：Burden of influenza in patients with cardiovascular disease who receive antiviral treatment for influenza
• DOI：10.6084/m9.figshare.20455939.v2
• 发布日期：2022-08-27
• 文件数：6 个
• 文件总体积：450.74 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Burden_of_influenza_in_patients_with_cardiovascular_disease_who_receive_antiviral_treatment_for_influenza/20455939

命令行下载

curl -L -o "ijme_a_2111910_sm6750.docx" "https://ndownloader.figshare.com/files/36896891"
curl -L -o "ijme_a_2111910_sm6746.docx" "https://ndownloader.figshare.com/files/36896894"
curl -L -o "ijme_a_2111910_sm6735.docx" "https://ndownloader.figshare.com/files/36896897"
curl -L -o "ijme_a_2111910_sm6726.docx" "https://ndownloader.figshare.com/files/36896900"
curl -L -o "ijme_a_2111910_sm6718.docx" "https://ndownloader.figshare.com/files/36896903"
curl -L -o "ijme_a_2111910_sm6710.docx" "https://ndownloader.figshare.com/files/36896906"

文件清单

• ijme_a_2111910_sm6750.docx（85.35 KB）
• ijme_a_2111910_sm6746.docx（89.64 KB）
• ijme_a_2111910_sm6735.docx（15.26 KB）
• ijme_a_2111910_sm6726.docx（89.03 KB）
• ijme_a_2111910_sm6718.docx（85.66 KB）
• ijme_a_2111910_sm6710.docx（85.80 KB）

文件总体积 450.74 KB（源站 API 实测）。

数据说明

Cardiovascular disease (CVD) increases the risk of complications from respiratory viruses, including influenza. Moreover, respiratory viruses may increase the risk of CV events. Antiviral medication may reduce healthcare resource utilization (HRU), but more data is needed in CVD populations to explore relationships between influenza antiviral treatment, CVD-related complications, HRU, and costs.
This retrospective claims analysis examined data extracted from IBM MarketScan Commercial Claims and Encounters and Medicare Supplemental and Coordination of Benefits databases during three influenza seasons: 2016–2017, 2017–2018, or 2018–2019. Propensity score matching was used to compare HRU outcomes and costs among CVD patients treated with influenza antivirals and untreated patients.
Across all influenza seasons, patients with CVD and influenza who received antiviral treatment had fewer all-cause emergency department (ED) visits (p p p p p p p p p CVD patients who contract influenza and take antiviral medication have fewer short- and long-term influenza-related complications and less overall HRU compared with CVD patients who were not prescribed antiviral treatments. Antiviral treatment may be an important tool in reducing complications in CVD patients with influenza.
People with heart disease are more likely to have complications from respiratory viruses, including influenza (flu). Moreover, respiratory viruses may increase the risk of damage to the heart muscle. We examined whether patients with heart disease who get the flu and take prescription medications called antiviral drugs have fewer short- and long-term flu-related complications and use fewer healthcare services than patients with heart disease who do not take antiviral drugs.
We examined commercial and Medicare databases during three influenza seasons (2016–2017, 2017–2018, and 2018–2019), and we compared outcomes and costs among heart disease patients who were treated or not treated with antiviral drugs. Patients with heart disease and the flu who received antiviral drugs had fewer visits to the emergency room, used fewer healthcare services for respiratory-related problems, used fewer heart disease-

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.20455939.v2（source: https://tandf.figshare.com/articles/dataset/Burden_of_influenza_in_patients_with_cardiovascular_disease_who_receive_antiviral_treatment_for_influenza/20455939）。